ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2085

A Survey on Giant Cell Arteritis-Related Knowledge Among Internal Medicine Residents

Helina Maharjan1, Muhammad Abdullah2, Summia Matin Afridi3, Alsayed Osman4, Aleena Sammar5 and Ahmad Raja6, 1Bassett Medical Center, Cooperstown, NY, 2Islamic International Medical College, Rawalpindi, Pakistan, 3Albany Medical Center, Albany, NY, 4AdventHealth Florida, Orlando, FL, 5Parkview Medical Center, Pueblo, CO, 6Mary Imogene Bassett Hospital, Evanston, IL

Meeting: ACR Convergence 2023

Keywords: giant cell arteritis, glucocorticoids

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Tuesday, November 14, 2023

Title: (2061–2088) Professional Education Poster

Session Type: Poster Session C

Session Time: 9:00AM-11:00AM

Background/Purpose: Giant Cell Arteritis (GCA) poses challenges in clinical practice, necessitating a deep understanding. Internal medicine residents play a crucial role in patient care and management. This study evaluates their comprehension of GCA diagnosis and management, aiming to identify knowledge gaps and develop tailored educational programs. GCA, a medical emergency with risks of blindness and cerebrovascular complications, relies on diagnostic tools such as imaging and biopsies alongside clinical judgment. Glucocorticoids form the foundation of treatment, while future strategy involve targeted biologics. Enhancing training and addressing knowledge gaps empower residents to effectively identify and manage GCA, ensuring optimal patient outcomes.

Methods: An 18-item questionnaire was developed following the latest guidelines from the ACR and EULAR. A cross-sectional survey was conducted among residents from three different programs located in New York, Colorado, and Florida. The questionnaire encompassed 11 questions related to the presentation, diagnosis, and management of GCA. The remaining questions were focused on assessing the residents’ comfort level in diagnosing and managing GCA patients, as well as evaluating their educational training in this area.

Results: Out of 107 participants, 48 (approximately 44%) completed the survey, yielding significant insights. The response rates varied across different levels of training, with 27% of PGY1, 33.33% of PGY2, and 37% of PGY3 participants providing their feedback. While 40% of respondents expressed satisfaction with their instruction, around 41% admitted to not attending teaching sessions, and 47% had no experience in caring for GCA patients. Surprisingly, although 56% felt confident in diagnosing GCA, only 31% were comfortable managing such patients. Furthermore, only 37% demonstrated familiarity with FDA-approved GCA medications. While 90% correctly identified prednisone as the initial drug of choice, only 50% knew the recommended dosage. Awareness of alternative diagnostic methods and appropriate ocular symptom management was limited among the participants. However, 89% acknowledged the importance of annual DEXA scans for monitoring bone health. These findings highlight the specific areas that require further education and training in the field of GCA.

Conclusion: The findings of this study reveal significant limitations in the understanding of GCA recognition and treatment among internal medicine residents. Although some residents expressed confidence in diagnosing GCA, there was a notable lack of familiarity with FDA-approved medications and discomfort in managing patients. Challenges were identified in comprehending initial dosages, utilizing alternative diagnostic techniques, and addressing ocular symptoms. These findings emphasize the critical need for targeted educational initiatives aimed at bridging these gaps and improving GCA care and management. By enhancing residents’ understanding, we can strive for better patient outcomes and advance the management of GCA.


Disclosures: H. Maharjan: None; M. Abdullah: None; S. Afridi: None; A. Osman: None; A. Sammar: None; A. Raja: None.

To cite this abstract in AMA style:

Maharjan H, Abdullah M, Afridi S, Osman A, Sammar A, Raja A. A Survey on Giant Cell Arteritis-Related Knowledge Among Internal Medicine Residents [abstract]. Arthritis Rheumatol. 2023; 75 (suppl 9). https://acrabstracts.org/abstract/a-survey-on-giant-cell-arteritis-related-knowledge-among-internal-medicine-residents/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2023

ACR Meeting Abstracts - https://acrabstracts.org/abstract/a-survey-on-giant-cell-arteritis-related-knowledge-among-internal-medicine-residents/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology